Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$327M |
| 2 |
Chipotle Mexican Grill
CMG
|
+$271M |
| 3 |
Chevron
CVX
|
+$264M |
| 4 |
JPMorgan Chase
JPM
|
+$233M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$707M |
| 2 |
Johnson & Johnson
JNJ
|
+$396M |
| 3 |
Amazon
AMZN
|
+$312M |
| 4 |
Walmart Inc
WMT
|
+$285M |
| 5 |
Intuitive Surgical
ISRG
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.73% |
| 2 | Technology | 14.98% |
| 3 | Financials | 10.9% |
| 4 | Consumer Discretionary | 8.96% |
| 5 | Real Estate | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AFSI
1951
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $3.92M | ﹤0.01% |
270,012
-126,700
| -32% | -$1.84M |
|
|
DNR
1952
DELISTED
Denbury Resources, Inc.
DNR
| $3.92M | ﹤0.01% |
631,835
-466,400
| -42% | -$2.33M |
|
|
GEN
1953
DELISTED
Genesis Healthcare, Inc.
GEN
| $3.91M | ﹤0.01% |
2,895,611
+471,411
| +19% | +$747K |
|
1954
United-Guardian
UG
$33.3M
| $3.91M | ﹤0.01% |
242,000
+8,700
| +4% | +$160K |
|
1955
Apyx Medical
APYX
$126M
| $3.9M | ﹤0.01% |
549,700
+216,700
| +65% | +$1.2M |
|
1956
Cars.com
CARS
$648M
| $3.9M | ﹤0.01% |
+141,200
| New | +$3.95M |
|
|
ARR
1957
Armour Residential REIT
ARR
$2.37B
| $3.85M | ﹤0.01% |
34,304
+13,600
| +66% | +$1.59M |
|
|
GMS
1958
DELISTED
GMS Inc
GMS
| $3.85M | ﹤0.01% |
+166,000
| New | +$4.21M |
|
1959
Teck Resources
TECK
$32.4B
| $3.84M | ﹤0.01% |
159,386
-228,376
| -59% | -$5.49M |
|
1960
Surgery Partners
SGRY
$2.01B
| $3.83M | ﹤0.01% |
+232,400
| New | +$3.71M |
|
1961
Federal Signal
FSS
$7.71B
| $3.83M | ﹤0.01% |
143,100
-84,200
| -37% | -$2.13M |
|
|
SRRA
1962
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $3.83M | ﹤0.01% |
56,306
+12,133
| +27% | +$1.1M |
|
1963
JD.com
JD
$39.6B
| $3.83M | ﹤0.01% |
+146,600
| New | +$4.8M |
|
|
DALN
1964
DELISTED
DallasNews
DALN
| $3.82M | ﹤0.01% |
207,612
+3,997
| +2% | +$71.5K |
|
1965
Sinclair Inc
SBGI
$1B
| $3.82M | ﹤0.01% |
+134,700
| New | +$3.83M |
|
1966
ICF International
ICFI
$1.61B
| $3.82M | ﹤0.01% |
50,600
+26,400
| +109% | +$2.02M |
|
1967
Data I/O
DAIO
$30.8M
| $3.81M | ﹤0.01% |
728,875
+59,275
| +9% | +$333K |
|
1968
Suburban Propane Partners
SPH
$1.18B
| $3.81M | ﹤0.01% |
161,767
-54,300
| -25% | -$1.27M |
|
1969
Minerva Neurosciences
NERV
$187M
| $3.81M | ﹤0.01% |
37,900
+15,900
| +72% | +$1.19M |
|
1970
Cohen & Steers
CNS
$4.36B
| $3.79M | ﹤0.01% |
93,400
-255,700
| -73% | -$10.7M |
|
1971
ICL Group
ICL
$7.06B
| $3.79M | ﹤0.01% |
628,507
-129,093
| -17% | -$684K |
|
1972
Universal Technical Institute
UTI
$1.41B
| $3.77M | ﹤0.01% |
1,419,018
+13,612
| +1% | +$39.9K |
|
1973
Tronox
TROX
$985M
| $3.77M | ﹤0.01% |
315,800
-15,600
| -5% | -$256K |
|
1974
Valhi
VHI
$463M
| $3.77M | ﹤0.01% |
137,950
+9,625
| +8% | +$484K |
|
1975
LiveRamp
RAMP
$2.3B
| $3.77M | ﹤0.01% |
+76,200
| New | +$3.37M |
|
Similar funds
Jim Simons's Q3 2018 Portfolio in Review
As of Q3 2018, Jim Simons held 3,734 positions worth $97.3B, up 6% from $91.7B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Jim Simons's Q3 2018 filing shows 508 new, 1,623 increased, 1,169 reduced and 410 closed positions. Its largest new stake was JPMorgan Chase: 2,054,913 shares worth $232M. The largest sale was Apple, an estimated $707M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q3 2018 buy was JPMorgan Chase: 2,054,913 shares worth $232M.
- Jim Simons added most to Twenty-First Century Fox, Inc. Class A in Q3 2018, an estimated $327M increase.
- Jim Simons's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $396M.
- Jim Simons fully exited Apple in Q3 2018, selling an estimated $707M.
- Jim Simons's ten largest holdings make up 9.7% of its $97.3B portfolio in Q3 2018.
- Jim Simons opened 508 new positions and closed 410 in Q3 2018.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $97.3B.
Based on Renaissance Technologies's 13F filing for Q3 2018, filed 13 Nov 2018.